ArticleThe New England journal of medicine2016
FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
Article in The New England journal of medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Next-day residual effects of flibanserin on simulated driving performance in premenopausal women.Human psychopharmacology · 2017Trial
- Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial.Women's health (London, England)Trial
- Top Ten Tips Palliative Care Clinicians Should Know About Addressing Patient Sexuality and Intimacy in Serious Illness.Journal of palliative medicine · 2025Article
- Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM).ESMO open · 2025Review
- Addressing Sexual Health in Breast Cancer Survivors: Evidence-Based Practices and Clinical Considerations.Current treatment options in oncology · 2025Review
- First-time orgasm in a young man with lifelong anorgasmia after flibanserin use: a case report.Sexual medicine · 2023Article
- Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment.Pharmaceutics · 2022Article
- Accidental Flibanserin Ingestion in Children Causing Acute Respiratory and Central Nervous System Depression: What Health Care Professionals Need to Know.Obstetrics and gynecology · 2022Article
- Clinically Meaningful Benefit in Women with Hypoactive Sexual Desire Disorder Treated with Flibanserin.Sexual medicine · 2022Article
- Bremelanotide for Treatment of Female Hypoactive Sexual Desire.Neurology international · 2022Review
- Article
- "Online" and "at-home" versus traditional models of health care: enhancing access or impeding optimal therapeutics?Fertility and sterility · 2020Article
- The rodent vaginal microbiome across the estrous cycle and the effect of genital nerve electrical stimulation.PloS one · 2020Article
- Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women.Endocrine · 2019Observational
- Evaluation and Management of Hypoactive Sexual Desire Disorder.Sexual medicine · 2018Review
- Sex Differences in the Treatment of Sexual Dysfunction.Current psychiatry reports · 2018Review
- Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.Journal of women's health (2002) · 2017Article
- Managing Disability in Progressive Multiple Sclerosis.Current treatment options in neurology · 2016Review
- Flibanserin Approval: Facts or Feelings?Sexual medicine · 2016Article
- Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients.Drug safety · 2016Article
Corrections and comments
- Commented on by
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
26649985What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.